0001556754-14-000002.txt : 20140211 0001556754-14-000002.hdr.sgml : 20140211 20140211110208 ACCESSION NUMBER: 0001556754-14-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140211 DATE AS OF CHANGE: 20140211 EFFECTIVENESS DATE: 20140211 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Novira Therapeutics, Inc. CENTRAL INDEX KEY: 0001556754 IRS NUMBER: 800335638 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-183127 FILM NUMBER: 14592147 BUSINESS ADDRESS: STREET 1: 3805 OLD EASTON ROAD CITY: DOYLESTOWN STATE: PA ZIP: 18902 BUSINESS PHONE: 215-260-7276 MAIL ADDRESS: STREET 1: 3805 OLD EASTON ROAD CITY: DOYLESTOWN STATE: PA ZIP: 18902 D/A 1 primary_doc.xml X0707 D/A LIVE 0001556754 Novira Therapeutics, Inc. 3805 OLD EASTON ROAD DOYLESTOWN PA PENNSYLVANIA 18902 215-260-7276 DELAWARE MOLECMO Nanobiotechnologies Inc. None Corporation true Osvaldo Flores c/o Novira Therapeutics, Inc. 3805 Old Easton Road Doylestown PA PENNSYLVANIA 18902 Executive Officer Director George Hartman c/o Novira Therapeutics, Inc. 3805 Old Easton Road Doylestown PA PENNSYLVANIA 18902 Executive Officer Anthony Ford-Hutchinson c/o Novira Therapeutics, Inc. 3805 Old Easton Road Doylestown PA PENNSYLVANIA 18902 Director Scott Rocklage c/o 5AM Ventures 2200 Sand Hill Road, Suite 110 Menlo Park CA CALIFORNIA 94025 Director Tim Shannon c/o Canaan Partners 285 Riverside Avenue, Suite 250 Westport CT CONNECTICUT 06880 Director Gianni Gromo 3000 Sand Hill Road, Building 4, Suite 210 Menlo Park CA CALIFORNIA 94025 Director Daniel E. Geffken c/o Danforth Advisors LLC Damon Mill Square, Suite 6C W. Concord ME MAINE 01742 Executive Officer Gregory Korbel c/o Novira Therapeutics, Inc. 3805 Old Easton Road Doylestown PA PENNSYLVANIA 18902 Executive Officer Pharmaceuticals Decline to Disclose 06b true 0001556754-12-000001 2012-08-10 true true true true false 58230 29800000 27995233 1804767 Includes cash proceeds and proceeds of indebtedness of the Issuer converted in the offering. false 10 0 0 700000 true false Novira Therapeutics, Inc. Gregory Korbel Gregory Korbel Secretary 2014-02-11